Visualisation of the normal adrenals at SPET examination with 111In-pentetreotide

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 8, 2003, Pages 1169-1172

  Jacobsson, Hans ^a   Bremmer, Staffan ^a   Larsson, Stig A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

111In pentetreotide; Adrenals; Normal subjects; SPET

Indexed keywords

PENTETREOTIDE; PENTETREOTIDE IN 111;

ABDOMEN; ADRENAL GLAND; ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE DISPLAY; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SWEDEN;

ADOLESCENT; ADRENAL GLANDS; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0043237835     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1210-5     Document Type: Article

References (10)

1. Krenning EP, Bakker WH, Kooij PPM, et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-octreotide. J Nucl Med 1992; 33:652-658.
2. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20:716-731.
3. Krenning EP, Kwekkeboom DJ, Reubi J-C. Peptide receptor scintigraphy in oncology. In: Murray IPC, Ell PJ, eds. Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Edinburgh: Churchill Livingstone; 1996:859-870.
4. Merrick MV. Essentials of nuclear medicine, 2nd edn. Berlin Heidelberg New York: Springer, 1998.
5. Kwekkeboom D, de Jong M, Krenning EP. Somatostatin receptor scintigraphy. In: Sandler M, Coleman RE, Patton JA, Wackers FJT, Gottschalk A, eds. Diagnostic nuclear medicine, 4th edn. Philadelphia: Lippincott Williams & Wilkins; 2003: 735-746.
6. Reubi JC, Waser B, Schaer J-C, Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 2001; 28:836-846.
7. Breeman WAP, de Jong M, Kwekkeboom DJ, et al. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med 2001; 28:1421-1429.
8. 1-octreotide following ACTH therapy. J Nucl Med 1997; 38:1489-1491.
9. Gibril F, Reynolds JC, Chen CC, et al. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. J Nucl Med 1999; 40:539-553.
10. Kasperlik-Zeluska AA, Roslonowska E, Slowinska-Srzednicka J, et al. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol 1997; 46:29-37.